Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  38,562 results for ""Adamantane""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Di-mannosylation enhances the adjuvant properties of adamantane-containing desmuramyl peptides in vivo .

  • Authors : Paurević M; Department of Chemistry, Josip Juraj Strossmayer University Osijek, HR-31000 Osijek, Croatia. .; Maršavelski A

Subjects: Adamantane*/Adamantane*/Adamantane*/chemistry ; Adamantane*/Adamantane*/Adamantane*/analogs & derivatives ; Mannose*/Mannose*/Mannose*/chemistry

  • Source: Organic & biomolecular chemistry [Org Biomol Chem] 2024 Aug 14; Vol. 22 (32), pp. 6506-6519. Date of Electronic Publication: 2024 Aug 14.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101154995 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Copper-Based Complexes with Adamantane Ring-Conjugated bis (3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma.

  • Authors : Morelli MB; School of Pharmacy, Immunopathology and Molecular Medicine Unit, University of Camerino, via Madonna delle Carceri 9, 62032 Camerino, Italy.; Caviglia M

Subjects: Copper*/Copper*/Copper*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Jun 13; Vol. 67 (11), pp. 9662-9685. Date of Electronic Publication: 2024 Jun 03.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Discovery of adamantane-type polycyclic polyprenylated acylphloroglucinols that can prevent concanavalin A-induced autoimmune hepatitis in mice.

  • Authors : Tao B; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, PR China.; Li Y

Subjects: Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/drug therapy ; Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/prevention & control ; Adamantane*/Adamantane*/Adamantane*/pharmacology

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Mar; Vol. 144, pp. 107145. Date of Electronic Publication: 2024 Jan 23.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Design, synthesis, anti-infective potency and mechanism study of novel Ru-based complexes containing substituted adamantane as antibacterial agents.

  • Authors : Wang L; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science &Technology Normal University, Nanchang, 330013, China.; Liu L

Subjects: Adamantane*/Adamantane*/Adamantane*/pharmacology ; Ruthenium*/Ruthenium*/Ruthenium*/pharmacology ; Ruthenium*/Ruthenium*/Ruthenium*/chemistry

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Apr 15; Vol. 270, pp. 116378. Date of Electronic Publication: 2024 Apr 02.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Nascent pharmacological advancement in adamantane derivatives.

  • Authors : Ragshaniya A; Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India.; Kumar V

Subjects: Adamantane*/Adamantane*/Adamantane*/pharmacology; Structure-Activity Relationship ; Drug Development

  • Source: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2024 Mar; Vol. 357 (3), pp. e2300595. Date of Electronic Publication: 2023 Dec 21.Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 0330167 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.

  • Authors : Simonson DC; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Testa MA

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Nov 18; Vol. 109 (12), pp. e2261-e2272.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Stability-indicating HPLC for remogliflozin, vildagliptin, and metformin: Method development, validation, and greenness.

  • Authors : Acharya H; Department of Pharmaceutical Quality assurance, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa, Anand, 388421 Gujarat, India.; Kotadiya R

Subjects: Metformin*/Metformin*/Metformin*/analysis ; Drug Stability* ; Vildagliptin*/Vildagliptin*/Vildagliptin*/analysis

  • Source: Annales pharmaceutiques francaises [Ann Pharm Fr] 2024 Nov; Vol. 82 (6), pp. 1071-1081. Date of Electronic Publication: 2024 Jun 28.Publisher: Elsevier Masson Editeur Country of Publication: France NLM ID: 2985176R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Contact allergy to olanzapine and saxagliptin in a pharmaceutical industrial worker: A case report.

Subjects: Adamantane*/Adamantane*/Adamantane*/*analogs & derivatives; Adamantane*/Adamantane*/Adamantane*/adverse effects ; Dermatitis, Allergic Contact*/Dermatitis, Allergic Contact*/Dermatitis, Allergic Contact*/etiology

  • Source: Contact dermatitis [Contact Dermatitis] 2024 Jun; Vol. 90 (6), pp. 628-630. Date of Electronic Publication: 2024 Mar 06.Publisher: Wiley Country of Publication: England NLM ID: 7604950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0536

Record details

Read More Add to Saved list
×
Academic Journal

Fluorescence Enhancement of Adamantane-Modified Dyes in Aqueous Solution via Supramolecular Interaction with Methyl-β-cyclodextrin and Their Application in Cell Imaging.

  • Authors : Liu HJ; College of Chemistry, Chemical Engineering and Material Science, Soochow University, Jiangsu, Suzhou, 215123, P.R. China.; Zhang G

Subjects: Adamantane*/Adamantane*/Adamantane*/chemistry ; beta-Cyclodextrins*/beta-Cyclodextrins*/beta-Cyclodextrins*/chemistry; Fluorescent Dyes/Fluorescent Dyes/Fluorescent Dyes/chemistry

  • Source: Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2023 Nov 21; Vol. 29 (65), pp. e202302782. Date of Electronic Publication: 2023 Oct 05.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9513783 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3765

Record details

Read More Add to Saved list
×
Academic Journal

New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments.

  • Authors : Lapshina MA; Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia.; Shevtsova EF

Subjects: Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/pharmacology ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/therapeutic use ; Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/drug therapy

  • Source: Molecules (Basel, Switzerland) [Molecules] 2023 Nov 13; Vol. 28 (22). Date of Electronic Publication: 2023 Nov 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
  • 1-10 of  38,562 results for ""Adamantane""